AXIM BIOTECHNOLOGIES, INC. Marketable Securities
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Marketable Securities of $0 as of 2020-12-31, per its 10-K/A filed 2021-04-26.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2021-04-26
- 2020-12-31: Marketable Securities $0.00.
- 2020-09-30: Marketable Securities $0.00.
- 2020-06-30: Marketable Securities $0.00.
- 2020-03-31: Marketable Securities $109.04K.
| Period end | Marketable Securities |
|---|---|
| 2020-12-31 | $0.00 10-K/A · filed 2021-04-26 |
| 2020-09-30 | $0.00 10-Q/A · filed 2020-11-27 |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | $109.04K 10-Q/A · filed 2020-07-02 |
| 2019-12-31 | $213.75K 10-K/A · filed 2021-04-26 |
| 2019-09-30 | $404.52K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $288.40K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $175.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $150.00K 10-K/A · filed 2020-05-20 |
| 2017-12-31 | $0.00 10-K · filed 2019-04-08 |